Search Results - "Isitt, John J."

Refine Results
  1. 1

    Long-Term Cost-Effectiveness the Dexcom G6 Real-Time Continuous Glucose Monitoring System Compared with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in France by Roze, Stéphane, Isitt, John J., Smith-Palmer, Jayne, Lynch, Peter, Klinkenbijl, Brigitte, Zammit, Gerald, Benhamou, Pierre-Yves

    Published in Diabetes therapy (01-01-2021)
    “…Introduction The aim was to determine the long-term cost-effectiveness of the Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system versus…”
    Get full text
    Journal Article
  2. 2

    Cost-utility of real-time continuous glucose monitoring versus self-monitoring of blood glucose in people with insulin-treated Type 2 diabetes in Canada by Alshannaq, Hamza, Isitt, John J, Pollock, Richard F, Norman, Gregory J, Cogswell, Greg, Lynch, Peter M, Roze, Stéphane

    “…Aim: Clinical trials and real-world data for Type 2 diabetes have shown that real-time continuous glucose monitoring (rt-CGM) lowers glycated hemoglobin (A1c)…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Health-related quality of life of immune thrombocytopenic purpura patients: results from a web-based survey by Snyder, Claire F., Mathias, Susan D., Cella, David, Isitt, John J., Wu, Albert W., Young, Joan

    Published in Current medical research and opinion (01-10-2008)
    “…ABSTRACT Objective: To assess the health-related quality of life (HRQOL) of immune thrombocytopenic purpura (ITP) patients. Research design and methods: This…”
    Get full text
    Journal Article
  5. 5

    Analysis of EQ-5D scores from two phase 3 clinical trials of romiplostim in the treatment of immune thrombocytopenia (ITP) by Sanz, Miguel A., MD, Aledort, Louis, MD, Mathias, Susan D., MPH, Wang, Xuena, PhD, Isitt, John J., MS

    Published in Value in health (01-01-2011)
    “…Abstract Objective Utility-based measures of quality of life are recommended by some decision makers in health care. No studies have addressed changes in…”
    Get full text
    Journal Article
  6. 6

    Hemoglobin, Exercise Training, and Health Status in Patients With Chronic Heart Failure (from the HF-ACTION Randomized Controlled Trial) by Piña, Ileana L., MD, MPH, Lin, Li, MS, Weinfurt, Kevin P., PhD, Isitt, John J., MS, Whellan, David J., MD, MHS, Schulman, Kevin A., MD, MBA, Flynn, Kathryn E., PhD

    Published in The American journal of cardiology (01-10-2013)
    “…Anemia is common in patients with chronic heart failure (HF), with a prevalence ranging from 10% to 56%, and may be a risk factor for poor outcomes. Anemia in…”
    Get full text
    Journal Article
  7. 7

    134-OR: Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System vs. Self-Monitoring of Blood Glucose in Type 2 Diabetes Patients on Insulin in Canada by ISITT, JOHN J., ROZE, STEPHANE, COGSWELL, GREGORY, LYNCH, PETER M.

    Published in Diabetes (New York, N.Y.) (01-06-2022)
    “…A health economic analysis was conducted to determine the cost-effectiveness of a real-time continuous glucose monitoring (rt-CGM) system versus…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Measurement of utility values in the UK for health states related to immune thrombocytopenic purpura by Szende, Agota, Brazier, John, Schaefer, Caroline, Deuson, Robert, Isitt, John J., Vyas, Paresh

    Published in Current medical research and opinion (01-08-2010)
    “…Abstract Objective: To measure utility values associated with immune (idiopathic) thrombocytopenic purpura (ITP), as perceived by the United Kingdom (UK)…”
    Get full text
    Journal Article
  11. 11

    174-OR: Budget Impact Analysis (BIA) Comparing Real-Time Continuous Glucose Monitoring (RT-CGM) with Self-Monitoring of Blood Glucose (SMBG) for all U.S. Medicaid Enrollees with Type 1 Diabetes by MINSHALL, MICHAEL E., ISITT, JOHN J., GRAHAM, CLAUDIA, LYNCH, PETER M.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…A BIA was performed comparing clinical cost offsets for rt-CGM compared with SMBG for U.S. Medicaid enrollees with type 1 diabetes (T1D) over one year…”
    Get full text
    Journal Article
  12. 12

    Associations Between Hemoglobin Level, Resource Use, and Medical Costs in Patients With Heart Failure: Findings From HF-ACTION by Reed, Shelby D., PhD, Li, Yanhong, MD, Ellis, Stephen J., PhD, Isitt, John J., MS, Cheng, Sunfa, MD, Schulman, Kevin A., MD, Whellan, David J., MD, MHS

    Published in Journal of cardiac failure (01-10-2012)
    “…Abstract Background Reports that patients with heart failure and anemia incur greater costs and medical resource use have relied largely on data with limited…”
    Get full text
    Journal Article
  13. 13

    Cost-Effectiveness of a Real-Time Continuous Glucose Monitoring System Versus Self-Monitoring of Blood Glucose in People with Type 2 Diabetes on Insulin Therapy in the UK by Isitt, John J., Roze, Stéphane, Sharland, Helen, Cogswell, Greg, Alshannaq, Hamza, Norman, Gregory J., Lynch, Peter M.

    Published in Diabetes therapy (01-12-2022)
    “…Introduction Real-time continuous glucose monitoring (rt-CGM) involves the measurement and display of glucose concentrations, potentially improving glucose…”
    Get full text
    Journal Article
  14. 14

    Health-related quality of life in acute schizophrenia patients treated with RBP-7000 once monthly risperidone: An 8-week, randomized, double-blind, placebo-controlled, multicenter phase 3 study by Isitt, John J, Nadipelli, Vijay R, Kouassi, Alex, Fava, Maurizio, Heidbreder, Christian

    Published in Schizophrenia research (01-07-2016)
    “…Abstract Background There is increased interest in the impact of new long-acting treatments on health-related quality of life (HRQoL) in patients with…”
    Get full text
    Journal Article
  15. 15

    67-LB: Clinical Cost Offset Analysis Comparing Real-Time CGM (RTCGM) with SMBG Based on the COMISAIR 3-Year Follow-Up Study by SOUPAL, JAN, ISITT, JOHN J., GRUNBERGER, GEORGE, PRAZNY, MARTIN, PARKIN, CHRISTOPHER, MINSHALL, MICHAEL E., LYNCH, PETER M.

    Published in Diabetes (New York, N.Y.) (01-06-2020)
    “…This clinical cost offset analysis compared rtCGM vs. SMBG in people with type 1 diabetes (T1D) applying results from a 3-year, nonrandomized, prospective,…”
    Get full text
    Journal Article
  16. 16

    Evaluation of the Long-Term Cost-Effectiveness of the Dexcom G6 Continuous Glucose Monitor versus Self-Monitoring of Blood Glucose in People with Type 1 Diabetes in Canada by Roze, Stephane, Isitt, John J, Smith-Palmer, Jayne, Lynch, Peter

    Published in ClinicoEconomics and outcomes research (01-01-2021)
    “…The Dexcom G6 real-time continuous glucose monitoring (RT-CGM) system is one of the most sophisticated RT-CGM systems developed to date and became available in…”
    Get full text
    Journal Article
  17. 17

    Impact of ITP on physician visits and workplace productivity by Tarantino, Michael D., Mathias, Susan D., Snyder, Claire F., Isitt, John J., Gernsheimer, Terry, Young, Joan

    Published in Current medical research and opinion (01-02-2010)
    “…Abstract Objective: To assess the impact of immune thrombocytopenic purpura (ITP) on primary care and specialist visits and workplace productivity. Research…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Determining the Understandability and Acceptability of an Oral Mucositis Daily Questionnaire by Tomlinson, Deborah, Isitt, John J., Barron, Richard L., Doyle, John, Judd, Peter, Gassas, Adam, Naqvi, Ahmed, Sung, Lillian

    Published in Journal of pediatric oncology nursing (01-03-2008)
    “…Oral mucositis research in children receiving anticancer therapy has been impeded by the lack of an acceptable, appropriate assessment scale. Some scales…”
    Get full text
    Journal Article
  20. 20